PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

ibandronate vs risedronate

Side-by-side comparison of ibandronate and risedronate Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
ibandronate Bisphosphonate
risedronate Bisphosphonate
Type
ibandronate Prescription
risedronate Prescription
Summary
ibandronate

Ibandronate (Boniva) is a medicine that helps treat and prevent bone loss in women after menopause. It makes bones stronger and less likely to break.

risedronate

Risedronate sodium delayed-release tablets help treat osteoporosis after menopause. It helps to make your bones stronger and less likely to break.

What It Treats
ibandronate

Ibandronate is used to treat and prevent osteoporosis in women after menopause. Osteoporosis is a condition that makes bones weak and more likely to break. This medicine helps to increase bone strength and reduce the chance of fractures, especially in the spine.

risedronate

This medicine treats osteoporosis in women after menopause. Osteoporosis makes bones weak and more likely to break. Risedronate can lower the chance of breaks in the spine and other bones.

How It Works
ibandronate

Ibandronate belongs to a class of drugs called bisphosphonates. It works by slowing down the breakdown of bone. This helps to increase bone density and reduce the risk of fractures.

risedronate

Risedronate belongs to a class of drugs called bisphosphonates. It works by slowing down the breakdown of bone. This helps to increase bone density and reduce the risk of fractures.

Common Side Effects
ibandronate
  • Back pain
  • Upset stomach
  • Pain in arms or legs
  • Diarrhea
  • Headache
risedronate
  • Diarrhea
  • Flu-like symptoms
  • Joint pain
  • Back pain
  • Abdominal pain
FAERS Reports
ibandronate
  • Joint pain 243
  • Diarrhea 230
  • Feeling sick to your stomach 219
  • Broken thigh bone 216
  • Headache 198
risedronate
  • Joint pain 3,730
  • The medicine is not working 3,620
  • Pain 3,614
  • Feeling sick to your stomach 2,990
  • Feeling tired 2,911
Serious Warnings
ibandronate

This medicine can cause problems with your esophagus. To help prevent this, follow the directions carefully and stay upright for at least 60 minutes after taking it. Rarely, serious bone, joint, or muscle pain can occur. Tell your doctor if you have new pain in your thigh or groin. Osteonecrosis of the jaw (bone damage in the jaw) has been reported.

risedronate

Risedronate can cause problems with your esophagus. Follow the directions carefully and stay upright for 30 minutes after taking it. It can also cause bone, joint, or muscle pain. Tell your doctor right away if you have new pain in your thigh or groin.

Pregnancy
ibandronate

Ibandronate is not for use in women who can get pregnant. It is not known if this medicine will harm an unborn baby. Talk to your doctor if you are breastfeeding.

risedronate

Stop taking risedronate if you become pregnant. This medicine can affect the baby's bones. It is not known if risedronate passes into breast milk.

Also Compare — Nearby Drugs

Compare ibandronate with

Compare risedronate with

How to Read This ibandronate vs risedronate Comparison

ibandronate is classified in the Bisphosphonate drug class, while risedronate sits within the Bisphosphonate class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, ibandronate has 1,106 submissions while risedronate has 16,865. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between ibandronate and risedronate — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.